Brain

CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients

CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII),…

3 months ago

Synergy CHC Corp. Announces Closing of Initial Public Offering

WESTBROOK, Maine, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a provider of consumer health care,…

3 months ago

INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination

Data from Animal Model Study Demonstrate XPro™ converts microglia from a demyelinating cell to a remyelinating cell Multi-year study published…

3 months ago

Ayana Bio to Showcase Plant Cell Advantage™ Health & Wellness Ingredients at SupplySide West 2024

Ayana Bio's NeuroAdvantage and ImmunAdvantage prototypes will be available at SupplySide West booth #7071. BOSTON, Oct. 24, 2024 /PRNewswire/ --…

3 months ago

Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ACCESSWIRE / October 24, 2024…

3 months ago

BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024

- Continued, progressive improvement in motor function and achievement of motor milestones at 12-months post-treatment represents an important and statistically…

3 months ago

AlzeCure to Present at the International Partnering Conference Bioscience 2024 on November 7

STOCKHOLM, SE / ACCESSWIRE / October 24, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

3 months ago

MEDTEQ+ and AGE-WELL announce 16 envisAGE collaborative projects to enhance older adults’ quality of life with Canadian innovations

EDMONTON, AB, Oct. 23, 2024 /CNW/ - MEDTEQ+ and AGE-WELL proudly announce the first 16 collaborative projects resulting from an unprecedented national…

3 months ago

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

3 months ago

Soaak Technologies Selected to Present at the U.S. Air Force “Air Mobility Command” Fall Industry Preview Event on October 30th, 2024

Soaak's Groundbreaking Therapeutic Sound Frequency Compositions to Be Showcased as a Solution to Enhance Operational Wellness within the U.S. Air…

3 months ago